Targeted temperature management for acute ischemic stroke
Official title: Targeted Temperature Management for Neuroprotection in Acute Ischemic Stroke: A Randomized Controlled Pilot Trial
Run by Azienda Usl di Bologna · NCT07096687 · Data updated 2026-11-12
This trial tests if the CB240_Aurora device can keep temperature normal and improve recovery in adults with acute ischemic stroke due to middle cerebral artery occlusion within 48 hours.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 22 (estimated) |
| Sponsor | Azienda Usl di Bologna Government |
| Locations | 1 site (Bologna, Bologna) |
| Status | Recruiting |
| Started | September 11, 2025 |
| Main results expected | September 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | September 17, 2025 |
| Trial ID | NCT07096687 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with a first anterior circulation ischemic stroke due to MCA occlusion (M1–M3), NIHSS 6–25, symptom onset within 48 hours, axillary temperature 36–<37°C, and able to provide informed consent are ideal candidates.
✕Probably not a fit
Patients with intracerebral hemorrhage, strokes involving multiple vascular territories, pregnancy, significant pre-stroke disability (mRS >3), or contraindications to MRI or implanted pacemakers are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares active targeted temperature management using the CB240_Aurora device to a control arm in which the device only monitors temperature in adults with anterior circulation ischemic stroke. The CB240_Aurora targets cerebral temperature via vascular heat exchange in the neck and is worn continuously for 72 hours in the Stroke Unit. Outcomes include maintenance of normothermia and clinical and radiological measures recorded at 72 hours, 7 days, and 3 months. Enrollment requires imaging-confirmed MCA occlusion and NIHSS criteria, with exclusions for hemorrhage, multiple-territory stroke, pregnancy, significant pre-stroke disability, and MRI contraindications.
Why it matters
Potential benefit: If successful, this device could reduce secondary brain injury by preventing fever and maintaining brain temperature, potentially improving neurological recovery after acute ischemic stroke.
How similar studies have gone: Therapeutic hypothermia has proven benefit after cardiac arrest and neonatal HIE, but TTM for acute ischemic stroke has not shown clear clinical benefit to date, and neck-based cerebral cooling devices like the CB240_Aurora remain a relatively novel approach with limited clinical evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years; * Both sexes; * Diagnosis of acute ischemic stroke confirmed by clinical evaluation by a neurologist and neuroimaging (CT or brain MRI); * Acute ischemic stroke with symptom onset within 48 hours; * Anterior circulation stroke with evidence on neuroimaging (CT angiography) of occlusion of the middle cerebral artery in segments M1, M2, or M3; * NIHSS score between 6 and 25; * First clinical stroke; * Axillary temperature ≥36°C and \<37°C; * Informed consent obtained for study participation. Exclusion Criteria: * Stroke involving multiple vascular territories; * Presence of intracerebral hemorrhage; * Pregnancy; * Moderate-to-severe or severe pre-stroke disability defined as mRS \>3; * Presence of a cardiac pacemaker or any other conditions contraindicating brain MRI.
Where it's running
-
IRCCS Istituto delle Scienze Neurologiche di Bologna - AUSL of Bologna
Bologna, Bologna, Italy Recruiting
Study contacts
- Principal investigator: Andrea Zini — IRCCS Istituto delle Scienze Neurologiche di Bologna - AUSL of Bologna
- Study coordinator: Andrea Zini
- Email: a.zini@ausl.bologna.it
- Phone: +390516478810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)
This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
-
Photon-counting CT to check intracranial stents
This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.